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THE CONSUMPTION OF ALCOHOL is common in many societies. It has been well recognized since the early 1970s that the consumption of alcohol during pregnancy is teratogenic to the fetus, resulting in a number of neurological and developmental abnormalities, as well as slowing fetal growth (11, 43) . The umbrella term for the well-characterized behavioral and developmental abnormalities that arise from fetal alcohol exposure is known as fetal alcohol spectrum disorder, and the variety of effects ranges from mild to severe, with fetal alcohol syndrome being at the most severe end of the spectrum (43) . The variable effects are most likely due to the level, timing, and/or duration of fetal alcohol exposure.
Although it is recommended in many countries, including Australia, Canada, New Zealand, the United States, and the Netherlands that pregnant women abstain from alcohol during pregnancy (19) , many pregnant women continue to drink. Data generated from the Australian 2001 National Health Survey showed that almost 27% of women consumed alcohol while pregnant, with more than 25% of these women having consumed up to seven standard drinks (standard drink ϭ 10 g alcohol) over 1-3 days during the reference week of the survey (19) . It is quite likely that the incidence of alcohol consumption was underreported in this self-reporting National Health Survey. Regardless, this study, and many others like it, demonstrate that pregnant women are consuming alcohol in low-tomoderate amounts and not in the high amounts that are modeled in many animal models of fetal ethanol exposure (6, 25, 29, 44) . This highlights the importance of research into the effects of low-dose prenatal alcohol (ethanol) exposure.
Although a plethora of animal studies have explored the effects of prenatal ethanol (EtOH) exposure on both the fetus (13, 15, 30, 51) and offspring (1, 7, 20, 33) , few studies have considered the effects of maternal alcohol consumption during pregnancy on mammary gland function, lactation, and early postnatal offspring growth. This is of particular importance as with each pregnancy the mammary gland undergoes a period of differentiation and development in preparation for its role in lactation, followed by involution once the offspring is weaned off breast milk and the suckling reflex is removed. This pregnancy-associated, functional mammary gland development (secretory differentiation) begins with the onset of pregnancy (40) , and, therefore, it is likely that alcohol consumption during this time will alter secretory differentiation and subsequent lactation. Indeed, rat models of high EtOH consumption (20 -25% vol/vol) throughout pregnancy and the nursing period have demonstrated that EtOH decreases mammary gland weight (39, 53) , total milk quality (as indicated by increased fat concentration and decreased lactose concentration), and protein content (53) , and milk intake by the offspring (23, 35) . In addition, EtOH infusions given to lactating rats decrease both the maternal plasma oxytocin concentration and milk intake by pups (50) , presumably by decreasing maternal plasma prolactin concentrations (23) . Similarly, one human study also demonstrated that alcohol consumption during lactation decreases maternal plasma oxytocin and prolactin concentrations (32) , thereby impairing lactation. These studies indicate that alcohol has the potential to alter the function of the mammary gland, especially in high concentrations.
Secretory differentiation of the mammary gland can be altered by a number of insults. Animal models have shown that secretory differentiation is disrupted by maternal: uteroplacental insufficiency (55) , undernutrition (46) , obesity (17) , hypertension (56) , and vitamin A deficiency (8) . Most of these insults result in decreased mammary alveolar development. However, there is very little information regarding the effects of pregnancy-associated alcohol consumption on secretory differentiation of the mammary gland. One rat study has demonstrated that almost 50 days of high-dose EtOH consumption (starting 25 days prepregnancy) alters the volume fraction of alveolar epithelium and connective tissue within the mammary (48) , suggesting that alcohol has the potential to disrupt secretory differentiation. As most pregnant women consuming alcohol do so in low to moderate amounts and not the high amounts utilized by most animal models, the aim of this study was to determine whether low-to-moderate-dose EtOH consumption by the rat dam alters the structure of the mammary gland perinatally, the composition of milk proteins within the protein component of the milk and the concentration of hormones involved in secretory differentiation of the mammary gland and lactation. In addition, we examined milk intake and the growth of offspring during lactation.
MATERIALS AND METHODS

Animals
All animal procedures were approved by the Animal Welfare Unit of The University of Queensland and follow the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
Maternal Studies
Dams. Sprague-Dawley rats purchased from the Australian Research Council were used for this study. Female virgin rats of 15 Ϯ 1 wk of age and ϳ280 g were mated overnight, and the presence of seminal plugs indicated a successful mating. The day that seminal plugs were found was called embryonic (E) day 1. The pregnant rats were immediately allocated to receive an 80-ml liquid diet with or without 6% vol/vol ethanol (control, n ϭ 30; EtOH, n ϭ 30) for the entirety of pregnancy, as described previously (41) . This is a nutritionally complete diet that is approximately isocaloric to the diet provided to controls, with EtOH supplying ϳ15% vol/vol of calories. The liquid diet was provided fresh daily for the entirety of pregnancy, and the volume consumed was recorded daily. At E8, the maternal plasma EtOH concentration was determined to be 30 mg/dl (0.03%) at 30 min after the EtOH-containing diet was provided for the day (41) . A subset of pregnant dams was killed at E20 (1 ml/kg ip ketamine/xylazine, 1:1 mix; Lyppard Australia, Northgate, Queensland, Australia), and the left and right inguinal mammary glands were collected and weighed (control, n ϭ 9; EtOH, n ϭ 9). The left gland was fixed with a 10% vol/vol buffered formalin solution made from a 37% stock for histological analysis, while the right gland was snap frozen in liquid nitrogen for molecular analysis. The remaining dams were allowed to give birth and the day the pups were born was called postnatal day (PN) 0. Upon delivery of the pups, the liquid diet was removed and replaced with a standard laboratory rat chow diet, and water was offered ad libitum. A subset of these dams (control, n ϭ 11; EtOH, n ϭ 12) were killed at PN1 for collection of the right inguinal mammary gland. Once the gland was weighed, it was bisected, and one half was fixed in 10% vol/vol buffered formalin for histological analysis, while the second half was snap frozen in liquid nitrogen for molecular analysis and the determination of dry weight. At both E20 and PN1, maternal blood was collected via cardiac puncture after the diaphragm was pierced and the thoracic cavity was opened. The remainder of the pregnant dams (control, n ϭ 10; EtOH, n ϭ 9) was allowed to give birth and nurse their own offspring until weaning at PN28.
Plasma hormone concentrations. Blood collected at E20 and PN1 was centrifuged at 4°C and 3,000 g for 10 min, and the plasma was collected and stored at Ϫ20°C until assayed. Progesterone and estradiol 17␤ were measured in samples collected at E20 (n ϭ 8 -9). Prolactin was measured in samples collected at PN1 (n ϭ 9 -12). Plasma prolactin concentrations were measured by ELISA (catalog no. DEV9966; Demeditic Diagnostics, Kiel-Wellsee, Germany), with samples either assayed neat or diluted twofold in sample diluent. The assay sensitivity was 2.5 ng/ml, and the intra-assay coefficient of variation was 3.2%. Progesterone concentrations were measured by radioimmunoassay, as described previously (10) , except that antiserum C-9817 (Bioquest, North Ryde, New South Wales, Australia) was used. The extraction efficiency for this assay was 74.8%, and values reported here were not corrected for these losses. Plasma samples were assayed following a 10-fold dilution in assay buffer (0.05 M PBS with 0.1% wt/vol gelatin). The assay sensitivity was 0.2 ng/ml, and the intra-assay coefficient of variation was 6.0%. Plasma estradiol 17␤ concentrations were measured by a commercially available radioimmunoassay kit (catalog no. DSL4800; Immunotech, Prague, Czech Republic) with an assay sensitivity of 0.5 pg/ml and an intra-assay coefficient of variation of 4.2%.
Histomorphometry. Mammary tissue from the right inguinal gland of dams killed at PN1 was randomly sampled and embedded in glycol methacrylate resin (Technovit 7100 kit; Heraeus Kulzer) similar to that reported previously (9) . Briefly, the connective tissue separating the mammary gland from the surrounding structures (muscle and/or skin) was removed, and the gland was cut into 1-cm-long and 2-mm-thick slices. A random sampling grid was used to collect five pieces of tissue with a sampling fraction of ϳ1:6. These five tissue pieces were then embedded and sectioned exhaustively at 20 m. Every 30th section was stained with Periodic Acid Schiff. For analyses, images of the stained tissues were captured at ϫ25 magnification using an Aperio Scanscope XT histology slide scanner (Aperio Technologies, Vista, CA). Resulting images were viewed using ImageScope software (version 10.2.2.2319; Aperio Technologies). A grid was projected over the tissue image, and the number of points landing on mammary tissue, alveoli, lactiferous ducts, adipose tissue, blood vessels, lymph nodes, and "other" tissue (lymphatic vasculature and connective tissue) was recorded and categorized by one observer that was blinded to the experimental condition. This allowed the percentage of each structure within the tissue to be determined. One animal was counted three times to obtain a coefficient of variation of 1.4%.
The Cavalieri Principle (54) was used to estimate the volume of each mammary gland (Vm): Vm ϭ SF ϫ 30 ϫ T ϫ a(p) Ps, where SF is the inverse of the slice-sampling fraction of tissue, 30 is the inverse of the section-sampling fraction, T is the section thickness (20 m), a(p) is the area of single grid square, and Ps is the number of points that hit mammary tissue.
Relative gene expression. Following the extraction of total RNA using an RNeasy mini kit (Qiagen, Doncaster, Victoria, Australia), 1 g of RNA was reversed transcribed into cDNA using the TaqMan reverse transcription reagents kit (Applied Biosystems, Scoresby, Victoria, Australia). Real-time PCR was performed in the StepOne real-time PCR system (Applied Biosystems), and relative gene expression [in arbitrary units (AU)] was analyzed using the cycle of threshold fluorescence (Ct) method, as reported previously (47) . Genes of interest were either purchased as Assay on Demand (AOD; Applied Biosystems; FAM-labeled probe) or custom-designed (Table 1) . Each gene of interest [␣-lactalbumin (Lalba), ␤-casein (Csn2), whey acidic protein (Wap), vascular endothelial growth factor (Vegfa; AOD Mm00437304_m1), fms-related tyrosine kinase 1 (Flt1-VEGF receptor 1; AOD Mm00438971_m1), and kinase insert domain receptor (Kdr-VEGF receptor 2; AOD Mm01222431_m1)] was multiplexed with the house-keeping gene, 18s rRNA (VIC-labeled probe; TaqMan ribosomal RNA control reagents kit; Applied Biosystems). Reactions contained 50 ng of cDNA, 1ϫ mastermix (2ϫ Taqman Universal PCR Mastermix; Applied Biosystems), gene of interest (final concentration of 0.5 ϫ AOD or as shown in Table 1 ), 20 nM 18s forward primer, 80 nM 18s reverse primer, and 50 nM 18s probe (final volume of 20 l).
Protein expression. Total protein was extracted from 25-50 mg of mammary tissue taken from dams killed at PN1. 10ϫ volume of a standard RIPA lysis buffer was added to the tissues for homogenization with an IKA Ultra-Turrax T8 homogenizer (Labtek, Brendale, Queensland, Australia). At a temperature of 4°C, the homogenates were gently shaken for 50 min and centrifuged at 11,000 rpm for 20 min. The supernatant was collected and assayed for total protein content using the Bio-Rad DC protein assay kit (Bio-Rad, Gladesville, New South Wales, Australia). Fifty micrograms of protein per sample (control n ϭ 6; EtOH n ϭ 7) were subject to SDS-PAGE (4% vol/vol stacking, 15% vol/vol resolving), and the proteins were transferred to a Immobilon FL PVDF membrane (Merck Millipore, Kilsyth, Victoria, Australia). The membrane was blocked for 1 h at 4°C with 4% wt/vol fish gelatin in 1 ϫ PBS (Sigma-Aldrich, Sydney, New South Wales, Australia) prior to primary antibody incubation with the following conditions: goat polyclonal anti-LALBA (cat. no. sc-51456; Santa Cruz Biotechnologies, Santa Cruz, CA) and rabbit polyclonal anti-WAP (cat. no. sc-25526; Santa Cruz Biotechnologies), 1:500 dilution, 60 min at room temperature; mouse polyclonal anti-␤-actin (cat. no. A1978; Sigma-Aldrich; endogenous control), 1:5,000 dilution, 60 min at room temperature. Following washes with 1ϫ PBS with 0.1% vol/vol Tween-20, the membrane was incubated at room temperature for 1 h with the appropriate fluorescent secondary antibodies (LI-COR IRDye 800 or 680; Millennium Science, Surrey Hills, Victoria, Australia). Protein expression levels of LALBA [Mr 22-27 in the rat (4, 42)], WAP [Mr 21 in the rat (27, 31) ], and ␤-actin (Mr 42) were analyzed using the LI-COR Odyssey infrared imaging system (Millennium Science) using the 800-nm and 700-nm wavelengths, and the ratio between the two was determined.
Postnatal Studies
Litter size was not manipulated at term, but litters containing less than 7 or more than 15 pups, inclusive, were excluded from postnatal studies. Pups were toe-tagged on PN5 for identification purposes.
Pup growth. Control and EtOH-exposed male and female pups were weighed daily from PN1 to PN28 to assess postnatal growth; combined weights of male or female offspring per litter were recorded between PN1 and PN4 and averaged for the number of pups per sex; individual pup weights were recorded from PN5 when the offspring could be individually identified. On PN3, PN6, PN9, PN12, and PN15, pup body dimensions (head width, crown to snout length, and snout to rump length) were recorded using digital calipers (Scientific Py, Yamba, New South Wales, Australia).
Milk intake studies. Milk intake was measured at PN3, PN6, PN9, PN12, and PN15 via the weigh-suckle-weigh technique (38) . Briefly, pups were separated from their mothers for 1 h to allow milk accumulation within the maternal mammary glands. Pups were weighed immediately prior to being returned to their mothers and after a 3-h suckling period. Weight gain of pups over the 3-h refeeding period provided an indirect measure of pup milk intake.
Statistical Analyses
Data collected from the dams were compared between groups using a Student's t-test. For maternal daily dietary consumption, caloric intake, weight gain during pregnancy, and gestational length, data from dams killed at E20 and PN1 and dams that nursed their pups were combined. For E20 mammary gland Csn2 mRNA expression, the data were normalized via log10 transformation prior to analysis; for PN1 mammary gland Kdr mRNA expression, a Mann-Whitney rank sum test was used. For offspring studies, n refers to litter size. Offspring weight at PN1 was analyzed via Students t-test with separate analyses of group comparisons for each sex. Offspring body dimensions (head length and width, crown-rump length, body weight) and milk intake (absolute and relative) were analyzed with two-way repeated-measures ANOVA for each sex, with age and prenatal exposure type as factors; data were transformed for normality as needed. Data are expressed as means Ϯ SE. A P value less than 0.05 was accepted as statistically significant.
RESULTS
Maternal Food Intake, Weight, and Pregnancy Outcome
Dietary consumption by the dams has been detailed elsewhere previously (41) . Briefly, for the cohort of dams included in this study, there was no difference between control and EtOH-fed dams in daily dietary consumption (31.5 Ϯ 0.8 ml/day vs. 29.6 Ϯ 0.8 ml/day, respectively) or caloric consumption (197 Ϯ 5 calories/day vs. 185 Ϯ 5 calories/day, respectively). Total weight gain during pregnancy was not different between groups (93.1 Ϯ 4.4 g for control and 92.6 Ϯ 4.3 g for EtOH-fed dams). On average, control dams had 11 offspring and EtOH-fed dams had 12 offspring (6 Ϯ 1 males and females for both groups). For control and EtOH-fed dams that gave birth to their pups, gestational length was 22.5 Ϯ 0.5 days, with no differences between groups.
Maternal Body and Mammary Gland Weight and Histomorphometry at Necropsy
There were no differences in body weight between control and EtOH-fed dams at E20 or PN1 (Table 2) . At both ages, there was no difference in the absolute or relative weight of the inguinal mammary glands between control and EtOH-fed dams ( Table 2) . . Similarly, the proportions of the structural composition of the right inguinal mammary gland (% alveoli, lactiferous ducts, adipose tissue, blood vessels, lymph nodes, and "other") were not different between EtOH-fed and control dams (Table 2) , nor was the volume of the mammary gland occupied by the various structures (data not shown).
Maternal Hormone Levels
Circulating levels of progesterone for dams killed at E20 were similar between groups: 41.4 Ϯ 2.9 ng/ml for controls and 37.8 Ϯ 5.0 ng/ml for EtOH-fed dams. For these same dams, circulating estradiol 17␤ concentrations were 11.9 Ϯ 1.7 pg/ml and 9.8 Ϯ 1.6 pg/ml for control and EtOH-fed dams, respectively (not different). For dams killed at PN1, plasma prolactin concentrations were also not different between groups (control: 27.1 Ϯ 10.1 ng/ml; EtOH-fed: 32.4 Ϯ 9.6 ng/ml).
Mammary Gene Expression
Although at E20 the mammary gland of EtOH-fed dams had increased mRNA levels for Lalba (ϩ40%), Vegfa (ϩ28%), Flt1 (ϩ26%), and Wap (ϩ19%), these were not significantly different to control (Table 3 ). There was no difference between groups in gene expression for Kdr or Csn2. At PN1, there was increased gene expression for Vegfa (ϩ76%), Kdr (ϩ46%), and Wap (ϩ27%) within the mammary gland of EtOH-fed dams; however, again mRNA levels were not significantly different to that of control (Table 3) . Gene expression for Flt1, Csn2, and ␣-La was similar between groups.
Protein Expression in the PN1 Mammary Gland
At PN1, the mammary gland from EtOH-fed dams contained significantly more LALBA protein than that from controls (P ϭ 0.036; Fig. 1 ). In contrast, mammary gland protein levels for WAP was significantly lower (P ϭ 0.013; Fig. 1 ) for EtOH-fed dams than controls.
Offspring Growth and Milk Intake
For this study, the weight of control and EtOH-exposed offspring at PN1 was not different between male (6.91 Ϯ 0.31 g vs. 6 .82 Ϯ 0.36 g) or female (6.89 Ϯ 0.23 g vs. 6.38 Ϯ 0.53 g) groups. This similarity in body weight between male and female groups was observed at PN3, PN6, PN9, PN12, and PN15 (Fig. 2 ). There were no differences between male or female offspring groups in head width, head length, or snout-rump length on PN3, PN6, PN9, PN12, or PN15 (Table 4) .
Overall, there was no difference in the absolute volume of milk consumed by male and female control and EtOH-exposed pups (Fig. 3, A and B) , as shown via two-way repeatedmeasures ANOVA. However, when expressed as a percentage of control, EtOH-exposed pups were seen to have consumed less milk on PN3, PN6, and PN9 (males: Ϫ22%, Ϫ32%, and Ϫ23%, respectively; females: Ϫ19%, Ϫ32%, and Ϫ15%, respectively) (Fig. 3C) . Data are expressed as means Ϯ SE. Protein levels between groups were compared using Students t-test. *P Ͻ 0.05.
DISCUSSION
It is currently unknown whether there is a safe limit of alcohol consumption for pregnant women. Although many studies have explored the effects of maternal high-dose EtOH consumption during pregnancy, few of these have explored the role of gestational alcohol consumption on the maternal mammary gland. In the present study, we explored the effects of gestational low-to-moderate dose EtOH consumption on structural and functional aspects of the maternal mammary gland in the rat. We found that maternal hormone concentrations and the architecture of the early lactating mammary gland were unaltered by our EtOH-feeding regiment. However, the pups of dams exposed to ethanol consumed on average 15% less milk than pups of control dams, and the composition of milk proteins within the mammary gland was affected, which may have contributed to the maintained growth of offspring despite decreases in milk intake. These results indicate that although chronic low-to-moderate alcohol consumption during pregnancy may not alter mammary gland development, it may alter the milk consumption by pups and the composition of the total protein component of the milk secreted during lactation.
To fulfill the nutritional needs of the suckling neonate, the mammary gland needs to be adequately developed and produce milk of optimal quality and quantity. As pregnancy is a critical window for mammary gland development (16) , maternal insults occurring during this time have the potential to disrupt secretory differentiation of the mammary gland. In rodent models, alveolar size and number in the mammary gland can be decreased and lobular-alveolar development disrupted by maternal insults, including hypertension (56), uteroplacental insufficiency (55), obesity (17) , vitamin A deficiency (8) , and zinc deficiency (12) . In the present study of gestational lowto-moderate EtOH consumption [blood alcohol concentration (BAC) 30 mg/dl], we did not detect any alterations in mammary gland volume (or volume of particular tissue compartments) at PN1. A previous study of pregnant rats provided with drinking water containing 5% vol/vol EtOH from E11 until post mortem (BAC unknown) also reported very little difference in mammary gland morphology at birth or PN11 (24) . In contrast, dams fed a high-dose EtOH diet from 25 days premating until death (mean BAC 130 mg/dl), developed mammary glands with a reduced volume fraction of alveolar epithelium and increased volume fraction of connective tissue at PN2 but not PN10 (48) . This suggests that high doses of EtOH consumption may delay, but not disrupt, pregnancy-associated mammary gland development and that gestational EtOH consumption may affect mammary gland development in a manner that is dependent upon the timing and/or length of EtOH exposure.
Progesterone, estradiol, and prolactin, in combination with growth hormone and insulin-like growth factor 1, are necessary for ductal morphogenesis and lobular-alveolar development (reviewed in Refs. 26 and 36) . Delivery of these hormones is dependent upon an adequate blood supply; hence, angiogenesis and lobular-alveolar expansion and differentiation occur concurrently within the mammary gland (14) . One of the most important regulators of angiogenesis in the mammary gland is VEGFa. Inactivating VEGFa in pregnant mice downregulates Kdr (Vegf-R2), decreases vascularization, and prevents lobularalveolar expansion into the mammary fat pad (45) . In the present study, we detected increases in Vegfa, Flt1, and Kdr gene expression within the mammary gland of EtOH-fed dams; however, none of these changes reached statistical significance. While it is possible that low-to-moderate EtOH consumption throughout pregnancy does not alter angiogenesis, as glandular development continues during lactation, the tendency for elevations in Vegfa gene expression may result in more blood vessels at a later stage of lactation. The hormonal milieu is also responsible for the onset and maintenance of lactation. Progesterone withdrawal at the end of pregnancy is necessary to initiate lactation (37, 28) , and suckling-induced prolactin (2) and oxytocin (5) release, in combination with milk removal, are responsible for the maintenance of lactation. In the rat, uteroplacental insufficiency has been shown to induce premature withdrawal of progesterone in late gestation, thereby stimulating early onset milk production (55) . In our model of low-to-moderate EtOH consumption, circulating levels of progesterone and prolactin were unaltered, suggesting that the initiation and maintenance of lactation was not disrupted by EtOH.
In the present study, EtOH-exposed pups consumed on average, 15% less milk than controls, with a maximal decrease of 32% on PN6. It is surprising that this did not cause decreased postnatal growth. There are a number of possible explanations for this phenomenon. First, pups from EtOH-fed dams may have had an increased number/length of suckling periods per day, thus providing the same total daily milk intake as controls. A second, and perhaps more likely, explanation is an altered composition of milk produced by EtOH-fed dams. To determine this would require separate multiple cohorts of rats at differing stages of lactation for analyses. Deficits in milk quality/quantity has been previously reported in rat models of high-dose gestational EtOH consumption, as indicated by decreased total protein, lactose, and carbohydrate concentrations and/or amino acid and fat content (22, 53) . Other dietary interventions can also alter milk composition. A 15% caseindeficient diet decreases milk volume (21, 34) and LALBA content (21) in rats. In contrast, rats fed a 30% proteinrestricted diet were found to produce milk with decreased total protein and casein content (49) . In humans, a low-protein diet during breastfeeding increases ␣-LA protein concentrations; however, for that study, only three women were included, and the low-protein diet was administered for only 4 days (18). In the current study, we examined the gene and protein levels of milk proteins (␣-lactalbumin, ␤-casein, and whey acidic protein) within the mammary gland, as we were unable to "milk" sufficient volumes of milk from the mammary gland at necropsy. As milk is produced within the mammary gland before it is secreted into the ductal network for its delivery to the suckling offspring, we believed it was appropriate to analyze the tissue as a proxy marker the protein component of milk. Gene expression analysis revealed tissue mRNA levels of milk proteins were quite variable and despite up-regulations of 40% for Lalba at E20 and 26% for Wap at both E20 and PN1, these changes did not reach statistical significance. However, importantly, protein levels of LALBA were significantly increased and WAP significantly decreased at PN1. Our findings suggest that the milk produced by the EtOH-fed dams may have an increased lactose content and, therefore, caloric content as LALBA is the regulatory subunit of lactose synthetase (3) . If so, this may have sustained the growth of EtOH-exposed pups, despite their decreased milk intake. Although this may appear advantageous in the short term, the long-term effects of consuming such energy-rich milk in infancy are unknown, and we speculate it may contribute to increased adiposity and childhood obesity. These speculations may be clarified with the determination of milk lactose concentration in future studies of daily low-to-moderate EtOH consumption in pregnancy. It was surprising to find that protein levels of WAP were significantly decreased in the lactating mammary gland in EtOH-fed dams. This suggests decreased translation of the WAP gene. Previously, it has been shown that lactating WAP knockout mice are unable to adequately nourish their offspring, as indicated by decreased pup growth in the second half of the lactational period (52) . Despite decreased WAP protein expression in the mammary gland, rats in our study were able to adequately nourish their young as offspring growth was not affected. This suggests the decreased WAP content was not maintained throughout lactation. Future studies examining WAP content in the mammary gland at a later stage of lactation would be of interest.
One of the greatest limitations of this study was our inability to analyze milk composition (protein, fat, and carbohydrate content) and the protein levels of WAP and LALBA within the milk ingested by the offspring. This was due to difficulties in obtaining sufficient milk from dams at PN1. To determine whether low-to-moderate EtOH consumption during pregnancy alters lactation, future studies should examine the mammary tissue and collect milk at key periods of lactation, such as at the time of minimal milk intake by the pup (identified as PN6 in the current study), the time of maximal milk production by the dam (PN12 in the current study), and immediately prior to weaning of the pups. Such studies will be of great value as they will provide insight on the nutritional intake of the nursed offspring.
Perspectives and Significance
These studies demonstrate that although daily low-to-moderate EtOH consumption of the rat during pregnancy does not alter the functional development of the mammary gland, it increases tissue levels of LALBA protein. We suggest that this alteration ensures the offspring is adequately nourished, thereby, sustaining postnatal growth during lactation. While this would appear beneficial in the short term, the long-term consequences are unknown and warrant further investigation.
